Luu Brendan (CIK 0001842369)

Latest company ownership

ENTA - ENANTA PHARMACEUTICALS INC
Role: Chief Business Officer
Shares held
39,723
Last filed at
Dec 5, 2025
Confidence Score
45.8
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Dec 5, 2025 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 46.3 -1,394 -3.51% ✗ $19.8K
Dec 1, 2025 Dec 3, 2025 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 47.5 -498 -1.24% ✗ $7K
Feb 12, 2025 Feb 14, 2025 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 91.3 +4,174 11.58% ✗ $18.6K
Dec 6, 2024 Dec 10, 2024 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 46.3 -2,283 -5.96% ✗ $18.4K
Dec 1, 2024 Dec 3, 2024 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 47.5 -753 -1.93% ✗ $6.5K
Feb 12, 2024 Feb 14, 2024 ENANTA PHARMACEUTICALS INC Chief Business Officer Sell 86.3 +2,347 6.39% ✗ $12.1K
Dec 5, 2023 Dec 6, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, Business Dev. Sell 46.3 -2,125 -5.47% ✗ $20.5K
Dec 1, 2023 Dec 5, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, Business Dev. Sell 47.5 -753 -1.90% ✗ $7.1K
Feb 13, 2023 Feb 15, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, Business Dev. Sell 97.5 +13,889 53.99% ✗ $338.6K
Dec 1, 2022 Dec 5, 2022 ENANTA PHARMACEUTICALS INC Sr. VP, Business Dev. Sell 46.3 -498 -1.90% ✗ $22.1K
Feb 14, 2022 Feb 15, 2022 ENANTA PHARMACEUTICALS INC Sr. VP, Business Dev. Sell 91.3 +923 13.57% ✗ $30.6K